Showing results (921-930 of 1,515) with videos related to

Sort By:
Pageof 152
Movement Disorders Clinical Practice|October 27, 2018
Progressive Brain Atrophy in Alternating Hemiplegia of ChildhoodMasayuki Sasaki, Atsushi Ishii, Yoshiaki Saito, et al.
Movement Disorders Clinical Practice|October 27, 2018
Lung Function Testing On and Off Dopaminergic Medication in Parkinson's Disease Patients With and Without DysphagiaTareq Sawan, Mary Louise Harris, Christopher Kobylecki, et al.
Movement Disorders Clinical Practice|October 27, 2018
A Review of Clinical Outcomes for Gait and Other Variables in the Surgical Treatment of Idiopathic Normal Pressure HydrocephalusRichard Shaw, Neil Mahant, Erica Jacobson, et al.
Movement Disorders Clinical Practice|October 27, 2018
Nocturia in Parkinson's Disease: Why Does It Occur and How to Manage?Amit Batla, Véronique Phé, Lorenzo De Min, et al.
Movement Disorders Clinical Practice|October 27, 2018
Dopamine Transporter (DaT) Scan Utilization in a Movement Disorder CenterSrivadee Oravivattanakul, Lucas Benchaya, Guiyun Wu, et al.
Movement Disorders Clinical Practice|October 27, 2018
Associations Between Cardiovascular Events and Nonergot Dopamine Agonists in Parkinson's DiseaseJames A G Crispo, Allison W Willis, Dylan P Thibault, et al.
Movement Disorders Clinical Practice|October 27, 2018
High Botulinum Toxin-Neutralizing Antibody Prevalence Under Long-Term Cervical Dystonia TreatmentHarald Hefter, Dietmar Rosenthal, Marek Moll
Movement Disorders Clinical Practice|October 27, 2018
No Difference on Adherence Between Immediate-Release Versus Extended-Release Dopamine Agonists in Uninsured Subjects with Parkinson's DiseaseLisette Bazán-Rodríguez, Amin Cervantes-Arriaga, Rodrigo Llorens-Arenas, et al.
Movement Disorders Clinical Practice|October 27, 2018
Substantia Nigra Echogenicity Predicts Response to Drug Withdrawal in Suspected Drug-Induced ParkinsonismJose L López-Sendón Moreno, Araceli Alonso-Cánovas, Javier Buisán Catevilla, et al.
Movement Disorders Clinical Practice|October 27, 2018
Baseline Features Influencing the Effectiveness of Retraining Therapy for Writer's CrampJean-Pierre Bleton, Emmanuel Touzé, Laure Soulez-la-Rivière, et al.
Pageof 152